Latest
New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.
We know research matters to you. This month, explore our top articles of the year – featuring the MS-gut connection and other fresh off the press findings in MS research.
- Feb 2024
Participate in research aimed at learning more about the relationship between exercise and anxiety in people with MS, or exploring how women with MS may want to learn about sexual
- Feb 2024
Not enough time to read an entire newsletter? Our February newsletter snapshot contains the highlights in a quick, easy to read format.
Researchers are looking into the benefits and risks of alternative treatments for MS. Here are three recent studies with promising results!
Our ACP team is on the rise! This month, we are thrilled to welcome Grace Okafor. Spend a moment getting to know her!
- Feb 2024
We know how important research is to you, so this month we’re featuring new data on three popular complementary treatments for MS.
- Jan 2024
We know how important research is to you, so this month we’re bringing you highlights from the 2023 Leadership Summit. Meet Jen, a new member of the ACP team, and